Alnylam Pharmaceuticals (ALNY) Change in Inventory (2018 - 2026)

Alnylam Pharmaceuticals has reported Change in Inventory for 9 years, with the latest figure at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 153.48% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 105.38% YoY), and the FY2025 full-year result was -$8.5 million, up 37.65% from the prior year.
• Change in Inventory for Q1 2026 stood at $3.3 million, down from $13.9 million in the prior quarter.
• The five-year high for Change in Inventory was $19.0 million in Q4 2022, with the low at -$12.0 million in Q4 2023.
• Historically, Change in Inventory has averaged -$174764.7 across 5 years, with a median of -$1.9 million in 2022.
• The largest YoY upside for Change in Inventory was 1732.63% in 2025 against a maximum downside of 28150.0% in 2025.
• Alnylam Pharmaceuticals' Change in Inventory stood at $19.0 million in 2022, then tumbled by 163.18% to -$12.0 million in 2023, then surged by 92.92% to -$849000.0 in 2024, then soared by 1732.63% to $13.9 million in 2025, then sank by 76.02% to $3.3 million in 2026.
• The last three Change in Inventory figures came in at $3.3 million (Q1 2026), $13.9 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.